Publications

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

 115
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Next Article

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

A single-cell, long-read, isoform-resolved case- control study of FTD reveals cell-type-specific and broad splicing dysregulation in human brain

A single-cell, long-read, isoform-resolved case- contro...

 66

Homeostasis of megakaryocytes: balancing tissue residency and consumptive platelet production

Homeostasis of megakaryocytes: balancing tissue residen...

 44

Pseudomonas aeruginosa: persistence beyond antibiotic resistance

Pseudomonas aeruginosa: persistence beyond antibiotic r...

 147